BXNDA — BLS Pharmaceuticals Share News
0.000.00%
- AU$211.42m
- AU$209.18m
- AU$29.29m
Australia Stock Exchange release from BIOXYNE : Trading Halt Remains
Australia Stock Exchange release from BIOXYNE : Quarterly Activities/Appendix 4C Cash Flow Report
Brief: Bioxyne Trading Halt
Australia Stock Exchange release from BIOXYNE : Trading Halt
Australia Stock Exchange release from BIOXYNE : Pause in Trading
Australia Stock Exchange release from BIOXYNE : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from BIOXYNE : Annual Report to shareholders
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 16:47:12
Australia Stock Exchange release from BIOXYNE : Explanatory Note to the 2021 Annual Report
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 11:15:19
Australia Stock Exchange release from BIOXYNE : Preliminary Final Report
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:56:43
Australia Stock Exchange release from BIOXYNE : Appendix 4C - quarterly
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 15:55:42
Australia Stock Exchange release from BIOXYNE : Response to ASX Price Query
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 12:29:03
Australia Stock Exchange release from BIOXYNE : Appendix 4D and Half Year Accounts
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:04:24
Australia Stock Exchange release from BIOXYNE : Appendix 4C - Quarterly December 2020